Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection

Immunology

Volumn 95, Issue 1, 1998, Pages 69-75

  Pais, T F ^a,b   Silva, R A ^b   Smedegaard, B ^a   Appelberg, R ^b   Andersen, P ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; FEMALE; HOST RESISTANCE; MEMORY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ACYLTRANSFERASES; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI PROTEINS; FEMALE; GROEL PROTEIN; HSP70 HEAT-SHOCK PROTEINS; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, NUDE; MYCOBACTERIUM TUBERCULOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031657702     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00561.x     Document Type: Article

References (30)

1. WORLD HEALTH ORGANIZATION (1992) Tuberculosis control and research strategies for the 1990s: memorandum from W.H.O. Bulletin of the W.H.O. 70, 17.
2. GRIGG E.R.N. (1958) The arcana of tuberculosis with a brief epidemiologic history of disease in the USA. Part IV. Am Rev Tuberc 78, 583.
3. PFUETZE K.H., PYLE M.M., HINSHAW H.C. & FELDMAN W.H. (1955) The first clinical trial of streptomycine in human tuberculosis. Am Rev Tuberc 71, 752.
4. ROBITZEK E.H. & SELIKOFF I.J. (1952) Hydrazine derivatives of isonicotinic acid (Rimifon, Marsild) in the treatment of active progressive caseous-pneumonic tuberculosis. Am Rev Tuberc 65, 402.
5. KOCH R. (1897) Über neue Tuberkulinpräparate. Dtsch Med Wochenschr 14, 209.
6. HART P.D. (1967) Efficacy and applicability of mass BCG vaccination in tuberculosis control. Br Med J 1, 587.
7. WORLD HEALTH ORGANIZATION (1963) The WHO standard tuberculin text. World Health Organization, Geneva.
8. YOUMANS G.P. (1975) Relation between delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis 11, 109.
9. FINE P.E.M., STERN J.A.C., PÖNNIGHAUS J.M. & REES R.J.W. (1994) Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344, 1245.
10. ANDERSEN P. (1997) Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45, 115.
11. ROBERTS A.D., SONNENBERG M.G., ORDWAY D.J. et al. (1995) Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85, 502.
12. HORWITZ M.A., LEE B.-W.E., DILLON B.J. & HARTH G. (1995) Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 92, 1530.
13. TASCON R.E., COLSTON M.J., RAGNO S., STAVROPOULOS E., GREGORY D. & LOWRIE D.B. (1996) Vaccination against tuberculosis by DNA injection. Nat Med 8, 888.
14. ANDERSEN P., ASKGAARD D., LJUNGQVIST L., BENNEDSEN J. & HERON I. (1991) Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 59, 1905.
15. ANDERSEN P. & HERON I. (1993) Simultaneous electroelution of whole SDS-polycrilamide gels for the direct cellular analysis of complex mixtures. J Immunol Meth 161, 29.
16. BRANDT L., OETTINGER T., HOLM A., ANDERSEN Å.B. & ANDERSEN P. (1996) Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 157, 3527.
17. ORME I.M. (1988) Characteristics and specificity of acquired immunologie memory to Mycobacterium tuberculosis infection. J Immunol 140, 3589.
18. ANDERSEN P. & HERON I. (1993) Specificity of a protective memory immune response against Mycobaclerium tuberculosis. Infect Immun 61, 844.
19. ANDERSEN P., ASKGAARD D., LJUNGQVIST L., BENTZON M.W. & HERON I. (1991) T-cell proliferative response to antigens secreted from Mycobacterium tuberculosis. Infect Immun 59, 1558.
20. MURPHY E., HIENY S., SHER A. & O'GARRA A. (1993) Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J Immunol Meth 162, 211.
21. ANDERSEN P., ANDERSEN Å.B., SRENSEN A.L. & NAGAI S. (1995) Recall of long-lived immunity to Mycobaclerium tuberculosis infection in mice. J Immunol 154, 3359.
22. MACKAY C.R. (1991) T-cell memory: the connection between function, phenotype and migration pathways. Immunol Today 12, 189.
23. FLYNN J.L., GOLDSTEIN M.M., TRIEBOLD K.J., KOLLER B. & BLOOM B.R. (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89, 12013.
24. ORME I.M., MILLER E.S., ROBERTS A.D. et al. (1992) T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for a different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 148, 189.
25. LADEL C.H., BLUM C., DREHER A., REIFENBERG K. & KAUFMANN S.H.E. (1995) Protective role of γ/δ T cells and α/β T cells in tuberculosis. Eur J Immunol 25, 2877.
26. WIKER H.G. & HARBOE M. (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56, 648.
27. MACKANESS G.B. (1967) Resistance to intracellular infection. J Infect Dis 123, 439.
28. WIRSING VON KOENING C.H. & FINGER H. (1982) Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature 297, 233.
29. ORME I. (1988) Induction of 8onspecific 8cquired resistance and delayed-type hypersensitivity, but non specific acquired resistance, in mice inoculated with killed Mycobacteria vaccines. Infect Immun 56, 3310.
30. ANDERSEN P. (1994) Effective vaccination of mice against Mycobacterium tuberculosis with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62, 2536.